Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
Houlihan, CF; MCGOWAN, CR; Dicks, S; BAGUELIN, M; MOORE, DA J; MABEY, D; ROBERTS, CH; Kumar, A; Samuel, D; Tedder, R; GLYNN, JR;
2017
PLoS medicine, (2017).14 5 10.1371/journal.pmed.1002300.
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.
Van Minh, H; My, NT T; JIT, M;
2017
BMC health services research, (2017).17 1 10.1186/s12913-017-2297-x.
Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
Habib, MA; Soofi, S; COUSENS, S; Anwar, S; Haque, NU; Ahmed, I; Ali, N; Tahir, R; Bhutta, ZA;
2017
The Lancet Global health, (2017).5 6 10.1016/S2214-109X(17)30184-5.
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
WAJJA, A; Kizito, D; Nassanga, B; NALWOGA, A; Kabagenyi, J; Kimuda, S; Galiwango, R; Mutonyi, G; Vermaak, S; Satti, I; Verweij, J; Tukahebwa, E; COSE, S; Levin, J; KALEEBU, P; ELLIOTT, AM; McShane, H;
2017
PLoS neglected tropical diseases, (2017).11 5 10.1371/journal.pntd.0005440.
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine.
GREENWOOD, B; Dicko, A; Sagara, I; Zongo, I; Tinto, H; CAIRNS, M; KUEPFER, I; MILLIGAN, P; Ouedraogo, J-B; Doumbo, O; CHANDRAMOHAN, D;
2017
Malaria journal, (2017).16 1 10.1186/s12936-017-1841-9.
Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness.
Moberley, S; Licciardi, PV; Balloch, A; Andrews, R; Leach, AJ; Kirkwood, M; Binks, P; MULHOLLAND, K; Carapetis, J; Tang, ML K; Skull, S;
2017
Vaccine, (2017).35 22 10.1016/j.vaccine.2017.04.040.
Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.
DARBOE, A; DANSO, E; CLARKE, E; Umesi, A; Touray, E; Wegmuller, R; MOORE, SE; RILEY, EM; Goodier, MR;
2017
European journal of immunology, (2017).47 6 10.1002/eji.201746974.
Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.
Verani, JR; Baqui, AH; Broome, CV; Cherian, T; Cohen, C; Farrar, JL; Feikin, DR; Groome, MJ; Hajjeh, RA; JOHNSON, HL; Madhi, SA; MULHOLLAND, K; O'Brien, KL; Parashar, UD; Patel, MM; RODRIGUES, LC; Santosham, M; SCOTT, JA; SMITH, PG; Sommerfelt, H; Tate, JE; Victor, JC; Whitney, CG; Zaidi, AK; Zell, ER;
2017
Vaccine, (2017).35 25 10.1016/j.vaccine.2017.04.035.
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
Verani, JR; Baqui, AH; Broome, CV; Cherian, T; Cohen, C; Farrar, JL; Feikin, DR; Groome, MJ; Hajjeh, RA; JOHNSON, HL; Madhi, SA; MULHOLLAND, K; O'Brien, KL; Parashar, UD; Patel, MM; RODRIGUES, LC; Santosham, M; SCOTT, JA; SMITH, PG; Sommerfelt, H; Tate, JE; Victor, JC; Whitney, CG; Zaidi, AK; Zell, ER;
2017
Vaccine, (2017).35 25 10.1016/j.vaccine.2017.04.037.
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.
ODUTOLA, A; Ota, MO C; ANTONIO, M; Ogundare, EO; Saidu, Y; FOSTER-NYARKO, E; Owiafe, PK; Ceesay, F; Worwui, A; Idoko, OT; Owolabi, O; BOJANG, A; JARJU, S; Drammeh, I; KAMPMANN, B; GREENWOOD, BM; Alderson, M; Traskine, M; Devos, N; Schoonbroodt, S; Swinnen, K; Verlant, V; Dobbelaere, K; Borys, D;
2017
Vaccine, (2017).35 19 10.1016/j.vaccine.2017.03.071.